Alpha Wealth Funds’s Pfizer PFE Stock Holding History

Alpha Wealth Funds’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$258K	Buy	+9,000	New	+$239K	0.15%	31

Other funds holding PFE

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Alpha Wealth Funds's PFE Position: Q3 2026 in Review

Alpha Wealth Funds opened a new position in Pfizer (PFE) in Q3 2026: 9,000 shares worth $258K. The stake represents 0.15% of the portfolio and ranks #31 among its holdings.

1,958 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

Alpha Wealth Funds held 9,000 shares of Pfizer worth $258K as of Q3 2026.
Pfizer was a new Alpha Wealth Funds position in Q3 2026.
Pfizer made up 0.15% of Alpha Wealth Funds's portfolio in Q3 2026, its #31 holding.
1,958 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Alpha Wealth Funds's 13F filing for Q3 2026, filed 4 Nov 2026.